Reassessing NMPEA: A Scientific Update on Nitrosamine Risk Evaluation
Kevin Cross
Assessment of N-Nitrosamine impurities in pharmaceuticals under the ICH M7 guideline.
In Silico Insider Blog
Application Areas
Clinical Stage
Product
Advancing Chemical Safety: An In Silico Protocol for Endocrine Activity Assessment
Candice Johnson, PhD
Integration of (Q)SAR models with experimental data and expert review for endocrine activity assessments.
ICH M7: From Guideline to Practical Workflow
Candice Johnson, PhD
Implementing Protocol-Driven (Q)SAR Mutagenicity Assessments for Pharmaceutical Impurities.
Significance of Chemical Grouping in E&L Risk Assessment
Candice Johnson, PhD
In Silico Insider: Candice Johnson, PhD
New Features in Leadscope Model Applier 2025.0 and Their Role in Predictive Toxicology & Risk Assessment
Candice Johnson, PhD
In Silico Insider: Candice Johnson, PhD
Optimizing predictive models using knowledge derived from proprietary data
Candice Johnson, PhD
In Silico Insider: Candice Johnson, PhD
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.
